share_log

Bruush Oral Care | 6-K: Report of foreign private issuer (related to financial reporting)

Bruush Oral Care | 6-K: Report of foreign private issuer (related to financial reporting)

Bruush Oral Care | 6-K：外國發行人報告（業績相關）
美股SEC公告 ·  01/05 00:00

Moomoo AI 已提取核心訊息

Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest...Show More
Bruush Oral Care Inc. completed two significant financing transactions in January 2024. The company closed a private placement on January 1, 2024, with Generating Alpha Ltd., raising $500,000 through the issuance of a pre-funded common share purchase warrant exercisable for 16,500,000 common shares at $0.001 each. Additionally, Bruush Oral Care agreed to file a registration statement for these shares within 45 days post-closing. On the same day, the company also entered into a convertible note financing agreement with Generating Alpha Ltd. for up to $6 million, with an initial funding of $1.5 million received on January 5, 2024. The note, maturing in one year with an interest rate of 12% or WSJ Prime Rate plus 3.5%, is convertible into common shares at a price of $0.1625 per share or 80% of the lowest volume-weighted average price of the ten trading days prior to conversion. The note includes full ratchet anti-dilution protections and additional terms in the event of default. EF Hutton LLC served as the placement agent for the financing. The company is required to file an initial registration statement for the convertible note within 30 days following January 1, 2024.
Bruush口腔護理公司於2024年1月完成了兩項重要融資交易。公司於2024年1月1日與Generating Alpha Ltd.完成了定向增發，通過發行可練股票認購權向公司籌集了50萬美元，每股行使價爲0.001美元，可行使購買1650萬股普通股。此外，Bruush Oral Care同意在結束後的45天內爲這些股票提交註冊聲明。同一天，公司還與Generating Alpha Ltd.簽訂了可轉換債券融資協議，最高爲600萬美元，初始資金於2024年1月5日收到150萬美元。這筆到期日爲1年的債券的利率爲12%或WSJ Prime Rate加3.5%，可按每股0.1625美元或轉換前10個交易日的最低成交量加權平均價格的80%進行轉換。該債券包括完整的反稀釋保護和違約事件下的額外條款。EF Hutton LLC 擔任融資機構。公司需要在2024年1月1日後的30天內爲可轉換債券提交初始註冊聲明。
Bruush口腔護理公司於2024年1月完成了兩項重要融資交易。公司於2024年1月1日與Generating Alpha Ltd.完成了定向增發，通過發行可練股票認購權向公司籌集了50萬美元，每股行使價爲0.001美元，可行使購買1650萬股普通股。此外，Bruush Oral Care同意在結束後的45天內爲這些股票提交註冊聲明。同一天，公司還與Generating Alpha Ltd.簽訂了可轉換債券融資協議，最高爲600萬美元，初始資金於2024年1月5日收到150萬美元。這筆到期日爲1年的債券的利率爲12%或WSJ Prime Rate加3.5%，可按每股0.1625美元或轉換前10個交易日的最低成交量加權平均價格的80%進行轉換。該債券包括完整的反稀釋保護和違約事件下的額外條款。EF Hutton LLC 擔任融資機構。公司需要在2024年1月1日後的30天內爲可轉換債券提交初始註冊聲明。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

獨立文件8  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間